Lung Cancer Foundation of America logo
Donate
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Hope
  • Research
  • Life
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Donate
  • Hope
  • Research
  • Life

What Can We Help You Find?

Tag: genomic testing

What Do I Need to Know About Biomarker Testing?

Biomarker (or Genomic Diagnostic) testing is key in today’s world of precision medicine. Lung cancer biomarker testing is also known as tumor testing, genetic mutation testing, next generation sequencing (NGS) or genomic testing. It looks for changes in the...
Read More
|
Diagnosis

The Unexpected: Lung Cancer in Your 20s: Corey Wood’s Story

Senior Year Disrupted In a Flash In May, 2014, Corey Wood was your typical 22-year old college student. A senior at Cal Berkeley, she was juggling classes, a job, and an internship, all in preparation to graduate and begin...
Read More
|
Living with Lung Cancer Survivors

What is ALK positive lung cancer? And what are the options for treatment?

ALK positive (anaplastic lymphoma kinase positive, or ALK+) lung cancer occurs in 1 out of 25 non-small-cell lung cancer patients (NSCLC — the most common type of lung cancer). Younger patients — usually 55 and under — who have...
Read More
|
Diagnosis

Or Search Our Site By Topic:

Advocacy advocacy ALK+ awareness biomarker biomarker testing chemotherapy clinical trial Clinical Trials clinical trials combination therapy Detection Diagnosis diagnosis early detection education EGFR EGFR mutation Fundraising genomic testing immunotherapy Immunotherapy KRAS latest research Living with Lung Cancer Lung Cancer Info lung cancer research non-smoker NSCLC patient support personalized medicine radiation Research ROS1 SCLC small cell lung cancer speakers bureau stage 4 Survivors Targeted therapy targeted therapy Treatment treatment Tributes Uncategorized

More

  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy

Give with Confidence


      

Our Mission

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.



Latest In Research

03/9
2023

Keytruda Meets Trial Goals for Non-Small Cell Lung Cancer Treatment

In the phase 3 KEYNOTE-671 trial evaluating Keytruda (pembrolizumab) as preoperative treatment (a regimen given before and after surgier) in patients with resectable stage 2, 3a or 3b non-small cell lung cancer has met one of its primary e…

Sign up

Get the latest news about lung cancer research.

Connect with us



©2023 Lung Cancer Foundation of America. All Rights Reserved. EIN 20-8730839

Sponsors    |    Legal and Privacy    |    Media Contact    |   State Fundraising Notices